FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022030596> ?p ?o ?g. }

• W2022030596 endingPage "88" @default.
• W2022030596 startingPage "80" @default.
• W2022030596 abstract "Lysophosphatidic acid (LPA) is a bioactive lipid mediator of inflammation via the LPA receptors 1–6. We and others have previously described proinflammatory and profibrotic activities of LPA signaling in bleomycin- or lipopolysaccharide (LPS)-induced pulmonary fibrosis or lung injury models. In this study, we investigated if LPA signaling plays a role in the pathogenesis of systemic sepsis from an abdominal source. We report here that antagonism of the LPA receptor LPA1 with the small molecule ki16425 reduces the severity of abdominal inflammation and organ damage in the setting of peritoneal endotoxin exposure. Pretreatment of mice with intraperitoneal ki16425 eliminates LPS-induced peritoneal neutrophil chemokine and cytokine production, liver oxidative stress, liver injury, and cellular apoptosis in visceral organs. Mice pretreated with ki16425 are also protected from LPS-induced mortality. Tissue myeloperoxidase activity is not affected by LPA1 antagonism. We have shown that LPA1 is associated with LPS coreceptor CD14 and the association is suppressed by ki16425. LPS-induced phosphorylation of protein kinase C δ (PKCδ) and p38 mitogen-activated protein kinase (p38 MAPK) in liver cells and interleukin 6 production in Raw264 cells are likewise blunted by LPA1 antagonism. These studies indicate that the small molecule inhibitor of LPA1, ki16425, suppresses cytokine responses and inflammation in a peritoneal sepsis model by blunting downstream signaling through the LPA1-CD14–toll-like receptor 4 receptor complex. This anti-inflammatory effect may represent a therapeutic strategy for the treatment of systemic inflammatory responses to infection of the abdominal cavity. Lysophosphatidic acid (LPA) is a bioactive lipid mediator of inflammation via the LPA receptors 1–6. We and others have previously described proinflammatory and profibrotic activities of LPA signaling in bleomycin- or lipopolysaccharide (LPS)-induced pulmonary fibrosis or lung injury models. In this study, we investigated if LPA signaling plays a role in the pathogenesis of systemic sepsis from an abdominal source. We report here that antagonism of the LPA receptor LPA1 with the small molecule ki16425 reduces the severity of abdominal inflammation and organ damage in the setting of peritoneal endotoxin exposure. Pretreatment of mice with intraperitoneal ki16425 eliminates LPS-induced peritoneal neutrophil chemokine and cytokine production, liver oxidative stress, liver injury, and cellular apoptosis in visceral organs. Mice pretreated with ki16425 are also protected from LPS-induced mortality. Tissue myeloperoxidase activity is not affected by LPA1 antagonism. We have shown that LPA1 is associated with LPS coreceptor CD14 and the association is suppressed by ki16425. LPS-induced phosphorylation of protein kinase C δ (PKCδ) and p38 mitogen-activated protein kinase (p38 MAPK) in liver cells and interleukin 6 production in Raw264 cells are likewise blunted by LPA1 antagonism. These studies indicate that the small molecule inhibitor of LPA1, ki16425, suppresses cytokine responses and inflammation in a peritoneal sepsis model by blunting downstream signaling through the LPA1-CD14–toll-like receptor 4 receptor complex. This anti-inflammatory effect may represent a therapeutic strategy for the treatment of systemic inflammatory responses to infection of the abdominal cavity." @default.
• W2022030596 created "2016-06-24" @default.
• W2022030596 creator A5002497837 @default.
• W2022030596 creator A5002693615 @default.
• W2022030596 creator A5008254848 @default.
• W2022030596 creator A5011092199 @default.
• W2022030596 creator A5039380491 @default.
• W2022030596 creator A5053733739 @default.
• W2022030596 creator A5077130930 @default.
• W2022030596 date "2015-07-01" @default.
• W2022030596 modified "2023-10-09" @default.
• W2022030596 title "Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis" @default.
• W2022030596 cites W126284806 @default.
• W2022030596 cites W1856553761 @default.
• W2022030596 cites W1969870436 @default.
• W2022030596 cites W1974949452 @default.
• W2022030596 cites W1979859986 @default.
• W2022030596 cites W2002469066 @default.
• W2022030596 cites W2004301965 @default.
• W2022030596 cites W2009488626 @default.
• W2022030596 cites W2048674276 @default.
• W2022030596 cites W2055750901 @default.
• W2022030596 cites W2060668169 @default.
• W2022030596 cites W2061205998 @default.
• W2022030596 cites W2066999792 @default.
• W2022030596 cites W2077269159 @default.
• W2022030596 cites W2083107204 @default.
• W2022030596 cites W2085546442 @default.
• W2022030596 cites W2088296072 @default.
• W2022030596 cites W2091137365 @default.
• W2022030596 cites W2095698281 @default.
• W2022030596 cites W2098565708 @default.
• W2022030596 cites W2100823525 @default.
• W2022030596 cites W2114232709 @default.
• W2022030596 cites W2129827480 @default.
• W2022030596 cites W2131032222 @default.
• W2022030596 cites W2133616917 @default.
• W2022030596 cites W2137280118 @default.
• W2022030596 cites W2137834747 @default.
• W2022030596 cites W2153110023 @default.
• W2022030596 cites W2159374668 @default.
• W2022030596 cites W2165292725 @default.
• W2022030596 cites W2167993855 @default.
• W2022030596 cites W2205053345 @default.
• W2022030596 cites W2460918827 @default.
• W2022030596 cites W77603329 @default.
• W2022030596 doi "https://doi.org/10.1016/j.trsl.2015.01.008" @default.
• W2022030596 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4458421" @default.
• W2022030596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25701366" @default.
• W2022030596 hasPublicationYear "2015" @default.
• W2022030596 type Work @default.
• W2022030596 sameAs 2022030596 @default.
• W2022030596 citedByCount "24" @default.
• W2022030596 countsByYear W20220305962015 @default.
• W2022030596 countsByYear W20220305962016 @default.
• W2022030596 countsByYear W20220305962017 @default.
• W2022030596 countsByYear W20220305962018 @default.
• W2022030596 countsByYear W20220305962019 @default.
• W2022030596 countsByYear W20220305962020 @default.
• W2022030596 countsByYear W20220305962021 @default.
• W2022030596 countsByYear W20220305962022 @default.
• W2022030596 crossrefType "journal-article" @default.
• W2022030596 hasAuthorship W2022030596A5002497837 @default.
• W2022030596 hasAuthorship W2022030596A5002693615 @default.
• W2022030596 hasAuthorship W2022030596A5008254848 @default.
• W2022030596 hasAuthorship W2022030596A5011092199 @default.
• W2022030596 hasAuthorship W2022030596A5039380491 @default.
• W2022030596 hasAuthorship W2022030596A5053733739 @default.
• W2022030596 hasAuthorship W2022030596A5077130930 @default.
• W2022030596 hasBestOaLocation W20220305962 @default.
• W2022030596 hasConcept C126322002 @default.
• W2022030596 hasConcept C164027704 @default.
• W2022030596 hasConcept C170493617 @default.
• W2022030596 hasConcept C203014093 @default.
• W2022030596 hasConcept C2776252253 @default.
• W2022030596 hasConcept C2776661833 @default.
• W2022030596 hasConcept C2776914184 @default.
• W2022030596 hasConcept C2778384902 @default.
• W2022030596 hasConcept C2778690821 @default.
• W2022030596 hasConcept C71924100 @default.
• W2022030596 hasConcept C86803240 @default.
• W2022030596 hasConcept C98274493 @default.
• W2022030596 hasConceptScore W2022030596C126322002 @default.
• W2022030596 hasConceptScore W2022030596C164027704 @default.
• W2022030596 hasConceptScore W2022030596C170493617 @default.
• W2022030596 hasConceptScore W2022030596C203014093 @default.
• W2022030596 hasConceptScore W2022030596C2776252253 @default.
• W2022030596 hasConceptScore W2022030596C2776661833 @default.
• W2022030596 hasConceptScore W2022030596C2776914184 @default.
• W2022030596 hasConceptScore W2022030596C2778384902 @default.
• W2022030596 hasConceptScore W2022030596C2778690821 @default.
• W2022030596 hasConceptScore W2022030596C71924100 @default.
• W2022030596 hasConceptScore W2022030596C86803240 @default.
• W2022030596 hasConceptScore W2022030596C98274493 @default.
• W2022030596 hasFunder F4320332161 @default.
• W2022030596 hasIssue "1" @default.
• W2022030596 hasLocation W20220305961 @default.
• W2022030596 hasLocation W20220305962 @default.

• next